Tarsus Pharmaceuticals
TARS
TARS
74 hedge funds and large institutions have $252M invested in Tarsus Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 27 increasing their positions, 20 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
74
Holders Change
+5
Holders Change %
+7.25%
% of All Funds
1.18%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
10
Increased
27
Reduced
20
Closed
5
Calls
$6K
Puts
$30K
Net Calls
-$24K
Net Calls Change
-$891K
Top Buyers
| 1 |
BlackRock
New York
|
$18.3M |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
$1.23M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
$2.96M |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
$25.6M |
| 5 |
Citadel Advisors
Miami,
Florida
|
$657K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
76
Janney Montgomery Scott
Philadelphia,
Pennsylvania
| – | -$171K | -11,640 | Closed |
|
77
US Bancorp
Minneapolis,
Minnesota
| – | -$1.16K | -79 | Closed |
|
|
IA
78
IFP Advisors
Tampa,
Florida
| – | -$1K | -30 | Closed |
|
|
S
79
SignatureFD
Atlanta,
Georgia
| – | -$191 | -13 | Closed |
|